Global Cerebrospinal Fluid (CSF) Management Market Report 2018-2022

DUBLIN, May 25, 2018 /PRNewswire/ --

The "Cerebrospinal Fluid (CSF) Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global cerebrospinal fluid (CSF) management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period.

The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures.

The cerebrospinal fluid (CSF) management market is segmented by product, end user, and region. Based on product, the market is segmented into shunts and external drainage systems. The shunts market is expected to grow at the highest CAGR during the forecast period. The high growth in the shunts market can be primarily attributed to the growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries. Based on the type, the shunts segment is further segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP), and ventriculopleural (VPL). The external drainage systems segment is further segmented on basis of type into external ventricular drainage and lumbar drainage.

Based on end user, the global cerebrospinal fluid (CSF) management market is categorized into pediatric, adult, and geriatric. The pediatric segment is expected to register the highest CAGR during the forecast period. This can primarily be attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures in the pediatric population.

Geographic segments in this report include North America, Europe, Asia Pacific, and the RoW. North America accounted for the largest share of the market in 2017. The large share of this region can primarily be attributed to the rising prevalence of hydrocephalus, increasing funding for hydrocephalus research in the US, and the launch of organizations such as Hydrocephalus Canada.

The dearth of trained professionals and complications related to CSF shunts may challenge market growth to a certain extent during the forecast period. For instance, in South Africa, there were 0.061 neurosurgeons per 100,000 people in 2016. This unavailability of medical professionals in developing countries is likely to reduce the chances of diagnosis and treatment of conditions requiring CSF management.

The major players in this market include Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Global Cerebrospinal Fluid (CSF) Management Market: Market Overview
4.2 Cerebrospinal Fluid (CSF) Management Market, By End User and Region
4.3 Geographic Snapshot: Cerebrospinal Fluid (CSF) Management Market
4.4 Cerebrospinal Fluid (CSF) Management Market, By Product

5 Market Overview
5.1 Introduction
5.1.1 Drivers
5.1.1.1 High Prevalence of Hydrocephalus and the Subsequent Increase in the Number of Shunting Procedures
5.1.1.2 Growing Geriatric Population
5.1.2 Opportunities
5.1.2.1 Growing Healthcare Market in Developing Economies
5.1.3 Challenges
5.1.3.1 Dearth of Trained Professionals
5.1.3.2 Complications Related to CSF Shunts

6 Cerebrospinal Fluid (CSF) Management Market, By Product
6.1 Introduction
6.2 Shunts
6.2.1 Shunts Market, By Type
6.2.1.1 Ventriculoperitoneal (VP) Shunts
6.2.1.2 Ventriculoatrial (VA) Shunts
6.2.1.3 Lumboperitoneal (LP) Shunts
6.2.1.4 Ventriculopleural (VPL) Shunts
6.2.2 Shunts Market, By Valve Type
6.2.2.1 Fixed Valve Shunts
6.2.2.2 Adjustable Valve Shunts
6.3 External Drainage Systems
6.3.1 External Ventricular Drainage (EVD) Systems
6.3.2 Lumbar Drainage (LD) Systems

7 Cerebrospinal Fluid Management Market, By End User
7.1 Introduction
7.2 Pediatric End Users
7.3 Adult End Users
7.4 Geriatric End Users

8 Cerebrospinal Fluid Management Market, By Region
8.1 Introduction
8.2 North America
8.2.1 Us
8.2.2 Canada
8.3 Europe
8.3.1 EU5
8.3.2 RoE
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World

9 Market Share Analysis
9.1 Introduction
9.1.1 Medtronic
9.1.2 Depuy Synthes
9.1.3 B.Braun
9.1.4 Integra
9.1.5 Other Players

10 Company Profiles
10.1 Medtronic
10.2 Integra Lifesciences Holdings Corporation
10.3 B. Braun Melsungen
10.4 Spiegelberg GmbH & Co. Kg
10.5 SOPHYSA (A Subsidiary of TKB Group)
10.6 Natus Medical Incorporated
10.7 Dispomedica GmbH
10.8 Deltasurgical
10.9 Argi Grup
10.10 Moller Medical GmbH
10.11 G.SURGIWEAR LTD
10.12 Wellong Instruments Co., Ltd

For more information about this report visit https://www.researchandmarkets.com/research/4b7ghj/global?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets